    Maninder Hora | Nektar Therapeutics | ZoomInfo.com 

Maninder Hora's involvement in venture capital (via Reviva Pharmaceuticals Inc, Pdl Biopharma)































Want to see more?Want to find out who got funded, and who’s funding the next big thing? in real time? all across the world? tailored to your specific areas of focus?100+ deals per dayGet access to the most exhaustive worldwide funding watch on the web!Comprehensive funding informationKnow about who invested in a company, which sites covered the event, the funding history, etc.Exclusive insightsView original analytics such as most dynamic industries, most active investors, and more!Stay aware!Get emailed when deals critical to your business happen. Filter by region, industry and topics of interest.As seen onHave a login?Sign inRegister now!It's free!Use your social accountOr fill in the quick form:Register nowpromise we won't spamSign invia your social account:via your existing WGF account:Remember meRegister, it's freeForgot your password?SIGN INForgot your password?Enter your e-mail and we will send you your new password.reset passwordThe world's largest funding base/people/185414-maninder-horasection=people&subsection=detail&id=185414




			Search deals by company name, industry, location, investors...			
			




SEARCH


ManinderHoraGet alertedif Maninder Hora gets funded!Maninder HoraReviva Pharmaceuticals Inc - Scientific AdvisorPdl Biopharma - Vice President of Process Development & Product Operations & QualityDeals involving Maninder Hora$12,000,000 raised with Reviva Pharmaceuticals Inc on March, 2013$7,624,840 raised with Reviva Pharmaceuticals Inc on August, 2012Please note that all data is automatically extracted and errors can occur.The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.Some of the profile information was collected using the Crunchbase API. For more details on the profile, please check Maninder Hora on Crunchbase.Inaccurate Data? Help us improve WhoGotFunded: post a comment!


NKTR Maninder Hora Insider Trades for Nektar Therapeutics


































Bulletin






Investor Alert





















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Nektar Therapeutics

                  NASDAQ: NKTR
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Nektar Therapeutics



After Hours
 --Quotes are delayed by 20 min
Jul 28, 2017, 4:48 p.m.


NKTR

/quotes/zigman/89920/composite


$
22.84




Change

-0.07
-0.30%

Volume
Volume 22,293
Quotes are delayed by 20 min








/quotes/zigman/89920/composite
Previous close

$
			22.61
		


$
				22.91
			
Change

+0.30
+1.33%





Day low
Day high
$22.26
$22.99










52 week low
52 week high

            $11.41
        

            $24.88
        


















Insider Activity


Individual




Maninder Hora



Dr. Maninder Hora is Senior Vice President-Pharmaceutical Development at Nektar Therapeutics.
Dr. Hora was previously employed as Vice President-Product Operations & Quality by Abbott Biotherapeutics Corp., Vice President-Product Operations by PDL BioPharma, Inc., Vice President-Process & Product Development by Chiron Corp., Vice President by GlaxoSmithKline Plc, Vice President by Wyeth Pharmaceuticals, Inc., and Vice President-Process & Product Development by Novartis Pharmaceuticals Corp.
He received his undergraduate degree from Rani Durgavati University and a doctorate degree from the Indian Institute of Technology New Delhi.



Transactions


Date
Shares
Transaction
Value





05/16/2017
2,959


 
Disposition at $19.55 per share.


57,849


04/05/2017
180,000


 
Disposition at $21.7 per share.


3,906,000


04/05/2017
180,000


 
Derivative/Non-derivative trans. at $13.7 per share.


2,466,000


02/16/2017
2,195


 
Disposition at $13.14 per share.


28,843


12/13/2016
15,000


 
Award at $0 per share.


0


11/16/2016
1,654


 
Disposition at $13.96 per share.


23,090


08/16/2016
3,305


 
Disposition at $17.56 per share.


58,036


07/14/2016
26,000


 
Award at $0 per share.


0


05/17/2016
835


 
Disposition at $13.58 per share.


11,340


05/16/2016
2,167


 
Derivative/Non-derivative trans. at $0 per share.


0


02/17/2016
963


 
Disposition at $11.92 per share.


11,479


02/16/2016
2,166


 
Derivative/Non-derivative trans. at $0 per share.


0





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Mr. Howard W. Robin 
President, Chief Executive Officer & Director




Mr. John  Nicholson 
Chief Operating Officer & Senior Vice President




Mr. Gilbert M. Labrucherie 
Chief Financial Officer & Senior Vice President




Dr. Ivan Philip Gergel 
Chief Medical Officer & Senior VP-Drug Development




Dr. Stephen K. Doberstein 
Chief Scientific Officer & Senior Vice President




Dr. Mary  Tagliaferri 
Vice President-Clinical Development




Dr. Maninder  Hora 
Senior Vice President-Pharmaceutical Development




Ms. Jillian B. Thomsen 
Chief Accounting Officer & Senior VP-Finance




Ms. Jennifer  Ruddock 
Senior VP-Investor Relations & Corporate Affairs




Ms. Jodi A. Sievers 
Director-Investor Relations & Communications




Ms. Dorian  Hirth 
Senior VP-Human Resources & Facilities Operations




Mr. Mark A Wilson 
Secretary, Vice President & General Counsel




Dr. Carlo J. Di Fonzo 
Senior VP-Drug Development & Regulatory Affairs




Mr. Robert B. Chess 
Chairman




Mr. Joseph J. Krivulka 
Independent Director




Mr. R. Scott Greer 
Independent Director




Mr. Dennis L. Winger 
Independent Director




Mr. Roy A. Whitfield 
Independent Director




Mr. Christopher A. Kuebler 
Independent Director




Mr. Lutz  Lingnau 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




12:28 AM EDT
July 29, 2017


/marketstate/country/us
New York

	Closed


/marketstate/country/uk
London

	Closed


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
12:21aTesla: Standard Model 3 will cost $35,000, long-range model will cost $44,000
9:16pWall Street isn’t ready for a 1,100-point tumble in the Dow industrials
7:39pBarron's Buzz: Robo 2.0, Facebook and Twitter, Trading On News
7:29pA Wild Week in Washington 
6:32pThe dark side of cruises
6:32pThe highest paid athletes in the world, in one chart
6:31pO.J. Simpson made over $400,000 while in prison and won’t have to give any of it to the Goldman family
6:31p Trump to Police: 'Don't Be Too Nice'
6:31pHere are 10 co-workers you should avoid like the plague — especially in meetings
6:29pTop 10 most annoying people you may want to unfriend on Facebook 
6:29pThis is one person you should never unfriend on Facebook...
6:29p3 horrible ways typos could alter the course of your life
6:27pPaint your bathroom this color and boost your home’s selling price by $5,400
6:27pAmericans’ new badge of honor: ‘I was blocked by a celebrity!’
6:27p5 weird things I found out about America in my first 24 hours 
6:14pBeyond Tesla: 7 stocks driving the autonomous car revolution
6:14pThese 7 highly taxed companies need Congress to finally act on tax reform
6:11pWatch out: ‘Kids’ are making the most money in this stock market 
6:10p7 real ways for millennials to save money (not by brownbagging and skipping Starbucks)
6:09p‘Game of Thrones’: This computer model predicts who will be killed off — or survive
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,830.31

+33.76
+0.15%





nasdaq

/quotes/zigman/12633936/realtime
6,374.68

-7.51
-0.12%





s&p 500

/quotes/zigman/3870025/realtime
2,472.10

-3.32
-0.13%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15

























































Hora  Maninder - Redwood City, CA | Intelius



























Sign In



We found Hora  Maninder in Redwood City, CA


Hora  Maninder

                                                            Intelius found that Hora  Maninder  is  a female from Redwood City, CA.  We have connected them to
                3 addresses,
                2 phones,
                and 0 relatives or associates.
         






Get Report Now

Hora Has Lived In

Redwood City, CA
Emeryville, CA
New Haven, CT







Hora  Maninder



GenderFemale



Professional Status
Director, Formulation and Pharmaceutical Development at Chiron Corporation



Get Report Now










Want to know more about Hora? Get a comprehensive background report, find full phone numbers, and other contact information when available, all from billions of available public records.
            Continue below for more details about Hora, or use our people search engine to find others.
Get Background Check on Hora  Maninder
Get a Criminal Check on Hora  Maninder
Get a Public Record Report on Hora  Maninder
Get a People Search Report on Hora  Maninder


Hora  Maninder's Contact Information
Known Cities Lived In
Find out where Hora  Maninder has lived as well as Hora  Maninder's phone numbers and email addresses.




Hora  Maninder Has Lived in 2 States
California Address for Hora  Maninder


1400 S****** B*** 

Redwood City, CA


Has Lived In

Redwood City, CA
Emeryville, CA


Get Full Address Report










Phone Numbers Associated with Hora  Maninder

(650) ***-**** - Redwood City, CA 
(510) ***-****


Get Full Phone Report



Email Addresses Associated with Hora  Maninder

b*****n@***.com
h*******r@***.com


Get Email Report




Hora  Maninder's Professional Information
Information regarding Hora  Maninder's professional history.  Find out previous places Hora  Maninder has worked as well as dates employed.
            The following data is not guaranteed for accuracy and should not be used for employment, insurance, credit eligibility, or for any other purpose covered under the Fair Credit Reporting Act.


Hora  Maninder Has Worked at 2 Places
Company: Chiron Corporation
               Title: Director, Formulation and Pharmaceutical Development
Company: Abbott Laboratories Company
               Title: Hora Maninder Ph D
Hora  Maninder's Experience
Title: Director, Formulation and Pharmaceutical Development
               Company: Chiron Corporation
Job Details
               Chiron Corporation is a global biopharmaceutical company. The Company operates in three healthcare three-business units: blood testing, vaccines and biopharmaceuticals. Its Blood Testing is dedicated to preventing the spread of infectious diseases through the development and sale of blood-screening assays and equipment that protect the world's blood supply. Its vaccines segment offers approximately 20 influenza, meningococcal, travel, and pediatric and other vaccines. The biopharmaceuticals segment researches, develops, manufactures and markets a range of therapeutic products for cancer and infectious and pulmonary disease.(Source: 10-K)
Title: Hora Maninder Ph D
               Company: Abbott Laboratories Company
Job Details
               Company Size: $1 bil and above - Employee Range: 25,000 to less than 100,000
Additional Professional Information on Hora  Maninder

 See Hora  Maninder's LinkedIn Profile



Hora  Maninder's Social Network and Potential Email Matches
Find out potential social network profiles and potential email usernamed for Hora  Maninder


Hora  Maninder's known Social Networks And Potential Email Matches

Find all of Hora  Maninder's Social Network Profiles

Get Full Report

Search Social Networks
Including Facebook, LinkedIn, MySpace, Google, Twitter, Yahoo, Jigsaw, ZoomInfo and more



Potential Email Matches
Hora Maninder
Username Matches

                  HoraManinder
                  ManinderHora
                  Hora.Maninder
                  Maninder.Hora
                  Hora_Maninder
                  Maninder_Hora
                  Hora-Maninder
                  Maninder-Hora
                  HManinder
               


Popular Email Services

@gmail.com
@aol.com
@yahoo.com
@comcast.net
@hotmail.com
@msn.com
@rocketmail.com
@att.net
@sbcglobal.net
@ymail.com
@facebook.com
@mail.com
@bellsouth.net
@live.com
@earthlink.net
@cox.net
@prodigy.net
@me.com
@peoplepc.com
@juno.com
@rediffmail.com
@mindspring.com
@comcast.com
@charter.net
@outlook.com




All trademarks, product names, company names or logos on this page are the property of their respective owners.
Related People Searches
H Maninder







         Intelius is a leading provider of public data about people and their connections to others. Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the Fair Credit Reporting Act (FCRA). This site should not be used to determine an individual’s eligibility for credit, insurance, employment, housing or any other purpose covered by the FCRA. For employment or tenant screening services, please visit our partner Talentwise.
      

About Us
Site Map
About Our Reports
Blog
Help
Contact Us

© 2003 – 2017 PeopleConnect, Inc. d/b/a Intelius. All Rights Reserved.
         Privacy Policy - UPDATED
Terms of Service - UPDATED






What is the FCRA?
The Fair Credit Reporting Act ("FCRA") is a federal law that promotes the accuracy, fairness and privacy of information in the files of consumer reporting agencies.
Intelius does not provide consumer reports and is not a consumer reporting agency as defined by the FCRA. Intelius reports cannot be used for background checks related to consumer credit, insurance, employment, housing or any other purpose
                  prohibited under the FCRA.
You may not use any information obtained from Intelius for any purpose covered by the FCRA.
Find out more about the FCRA here.











 



Maninder Hora, Vice President, Process Development, Pdl Biopharma, Inc. | Spoke











































LOGIN



REGISTER








Add Company



Add Person



Add Topic




Login






Or



















Home | People | Maninder Hora


Advanced Search
FAQ




Javascript is disabled












Bio
EDIT













Maninder Hora

Alias or nickname



Vice President, Process Development, Pdl Biopharma, Inc.




Fremont, CA




Find other people named Maninder Hora




General Info


Biological Product (except Diagnostic) Manufacturing



Add Tags— eg, Finance, Business2Business...



MANINDER HORA, PH.D., VICE PRESIDENT, PROCESS DEVELOPMENT
 Maninder Hora, Ph.D. has recently joined PDL BioPharma as Vice President, Process Development. Before PDL BioPharma, Dr. Hora was Vice President of Process and Product Development at Novartis Pharma AG (formerly Chiron Biopharmaceuticals) in Emeryville, Calif.In this position, Dr. Hora led a large group of scientists and engineers who performed all activities relating to process, formulation, assay and device development of proteins, antibodies and small molecules for preclinical, clinical and lifecycle development stages of drug development. Prior to this, Dr. Hora held pharmaceutical and drug delivery-focused positions of increasing responsibility within Chiron. Dr. Hora served as a key member of various teams that successfully registered eight drugs/vaccines in the U.S.and Europe during his 20-year tenure at Chiron. Dr. Hora has also held positions at Wyeth Pharmaceuticals and GlaxoSmithKline PLC. Dr. Hora completed his Ph.D. in Bioengineering from the Indian Institute of Technology, Delhi, India and was a Fulbright Scholar at the University of Washington, Seattle prior to joining the industry.


Not who you're looking for?
Find other Maninder Horas on Spoke




Contact



Telephone



Email



Background Report



Public Records


powered by





Digital Info



www.pdl.com



N/A



N/A



N/A



N/A



N/A



N/A









Resume

EDIT
CAREER



Pdl Biopharma, Inc.

Vice President, Process Development





EDUCATION

EDIT

Add a Degree— eg, Bachelors in Business Administration








Blogs By Industry Voices


There are currently no Blogs by Industry Voices





Achievements and Recognition
EDIT


Add an achievement and/or recognition— eg, Man of the year, Forbes 2011...





Notable Links

EDIT


The links below are powered by Bing search results. Click edit to customize.





Videos
EDIT


Add a videofrom youtube or vimeo





EXECUTIVES & FEATURED PEOPLE AT Pdl Biopharma, Inc.








Andrew Guggenhime

Senior Vice President and Chief Financial Officer









May Chan-Liston

Sr. Manager, Clinical Affairs









Samuel Broder

Director









Christophe Degois

Senior Director, EU Commercial Operations









Jon Saxe

Director









Behrooz Najafi

Vice President, Information Technology









JEANMARIE Guenot

Vice President, Corporate And Business Development









Laurie Torres

Vice President
 Corporate Services









Peter Calcott

Vice President, Quality
















Created on Jun 06, 2011


by Spoke
 







Edited on Jun 06, 2011


by Spoke
 




PAGE COMPLETION

40%




Career




Summary




Website/Blog




Industry




Add Education



Add 3 Notable Links



Add a Video



Add a Social Network



Add 3 Achievements



Add a Photo



View More


View Less



SHARE THIS PAGE
















Add Page


Add Company
Add Person
Add Topic




Copy this code to embed a widget:



<div id="spoke-root"></div>
<script>(function(d, s, id) {
var js, sjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id)) return;
js = d.createElement(s); js.id = id;
js.src = "//www.spoke.com/assets/widget.js";
sjs.parentNode.insertBefore(js, sjs);
}(document, 'script', 'spoke-widget-js'));</script>
    <div class="spoke-widget" data-host="//www.spoke.com" data-type="person" data-id="3e1429c09e597c1003efd4a0" data-width="404" data-height="230" data-scroll="no" data-frame-border="none"></div>
    <div style="font-size: 9pt;"><a href="http://www.spoke.com/people/maninder-hora-3e1429c09e597c1003efd4a0">Maninder Hora</a> widget provided by <a href="http://www.spoke.com">Spoke</a></div>




Public Records
Our partner can help you find public records for Maninder.


More on









Some of Spoke's Content Providers








Become a Spoke Content Provider
Learn More












Maninder Hora - Nektar Therapeutics Insider Transactions | TipRanks   





Go ProLogin / Sign Up Follow✓Get Real Time TransactionsInsider DetailsManinder HoraNektar Therapeutics (NKTR)SVP Pharma Dev & Mfg Ops Not RankedManinder Hora's PerformanceManinder Hora has not reported any informative transactions and therefore cannot be ranked.How are Insiders Ranked? Insider Holdings 58.0% Nektar Therapeutics (NKTR) 42.0% PDL BioPharma (PDLI)$27KSee the Top Stocks by Insiders > Insider RolesNektar Therapeutics (NKTR): SVP Pharma Dev & Mfg OpsPDL BioPharma (PDLI): VP of Product OperationsSee the Top 25 Corporate Insiders > Most Profitable Insider TradeStock: Nektar Therapeutics (NKTR)Transaction Type: Informative SellDates: May 18, 2016 - May 18, 2017Gain: -43.1%See the Latest Stocks Traded by Insiders > Maninder Hora's Trading Historybased on Form 4 Follow✓Get Real Time TransactionsCompany NameInsider PositionHolding ValueLast TransactionLast Transaction  AmountLast Transaction DateNKTRNektar TherapeuticsSVP Pharma Dev & Mfg Ops$15,729Uninformative Sell$57,848.45May 18, 2017PDLIPDL BioPharmaVP of Product Operations$11,373See All Insider Trading from Today >You May Also LikeMeet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.Related LinksHow can I benefit from Insider Trading? >See the Top 25 Corporate Insiders >Go to Hot Stocks by Insiders >Find which stocks Insiders traded today >Become a TipRanks MemberGet the best Investing Tips & Hacks straight to your emailFree MembershipSubmitInsider Trading Daily NewsletterProfessional day-trading strategy based on predictive insider transactionsAnnual Return: +85.42%Learn More >Powered by

































Maninder Hora Ph.D. - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In




















Maninder Hora Ph.D.
Senior Vice President, Pharmaceutical Development and Manufacturing Operations at Nektar Therapeutics


View Full Profile
Are you Maninder Hora Ph.D.? Claim your profile


 


Sign up for Equilar Atlas and view Maninder Hora Ph.D.'s full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Maninder Hora Ph.D.'s  network and community.
												FOLLOW changes in Maninder Hora Ph.D.'s employment and money-in-motion.
												CONNECT with Maninder Hora Ph.D. through your network of contacts.
												








Maninder Hora Ph.D.'s Executive Work History


Current


Senior Vice President, Pharmaceutical Development and Manufacturing Operations, 
Nektar Therapeutics


Past
To view Maninder Hora Ph.D.'s complete executive work history, sign up now
Education


														 Ph.D., 
															Indian Institute of Technology


Age
63

 
 


Maninder Hora Ph.D.'s Biography



Maninder Hora, Ph.D. has served as our Senior Vice President, Pharmaceutical Development and Manufacturing Operations since August 2010. From July 2006 to July 2010, he held various executive positions most recently as Vice President, Product and Quality Operations at Facet Biotech Corporation (now Abbvie Biotherapeutics), a clinical stage biotechnology company, which was acquired in 2010 by Abbvie Biotherapeutics (formerly Abbot). From 1986 to 2006, Dr. Hora held positions of increasing responsibility with Chiron Corporation (acquired in 2005 by Novartis), a pharmaceutical company, serving most recently at Chiron as Vice President of Process ...
(Read More)

			Maninder Hora, Ph.D. has served as our Senior Vice President, Pharmaceutical Development and Manufacturing Operations since August 2010. From July 2006 to July 2010, he held various executive positions most recently as Vice President, Product and Quality Operations at Facet Biotech Corporation (now Abbvie Biotherapeutics), a clinical stage biotechnology company, which was acquired in 2010 by Abbvie Biotherapeutics (formerly Abbot). From 1986 to 2006, Dr. Hora held positions of increasing responsibility with Chiron Corporation (acquired in 2005 by Novartis), a pharmaceutical company, serving most recently at Chiron as Vice President of Process and Product Development. Dr. Hora has also held positions at Wyeth Pharmaceuticals and GlaxoSmithKline plc prior to joining Chiron. Dr. Hora served as a key member of various teams that successfully registered ten drugs or vaccines in the U.S. and Europe during his professional career. Dr. Hora completed his Ph.D. in Bioengineering from the Indian Institute of Technology, Delhi, India, and was a Fulbright Scholar at the University of Washington, and received his B.S. in chemistry from the University of Jabalpur.
		
Source: Nektar Therapeutics on 03/01/2017
		
	

 






Sign up for Equilar Atlas and view Maninder Hora Ph.D.'s full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Maninder Hora Ph.D.. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Maninder Hora Ph.D.'s  network and community.
												FOLLOW changes in Maninder Hora Ph.D.'s employment and money-in-motion.
												CONNECT with Maninder Hora Ph.D. through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Maninder Hora Ph.D.


















Maninder Hora Ph.D.'s Connections (26)





Sign up now to view Maninder Hora Ph.D.'s 26 connections »









Gil M. Labrucherie
Senior Vice President and Chief Financial Officer, Nektar Therapeutics









Francis W. Sarena
Chief Strategy Officer, Five Prime Therapeutics, Inc.









Dennis L. Winger
Board Member, Accuray Incorporated









David R. Parkinson
Board Member, Dare Bioscience, Inc.









Roy A. Whitfield
Board Member, Nektar Therapeutics









Mark A. McCamish
Former Senior Vice President and Chief Medical Officer, Facet Biotech









Rajiv De Silva
Former President and Chief Executive Officer, Endo International plc









Gary A. Lyons
Chairman of the Board, Rigel Pharmaceuticals, Inc.









Ivan P. Gergel
Senior Vice President, Drug Development and Chief Medical Officer, Nektar Therapeutics









Robert B. Chess
Chairman of the Board, Nektar Therapeutics








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993

















Maninder Hora - Senior Vice President, Pharmaceutical Development and Manufacturing Operations @ Nektar Therapeutics | crunchbase
czdryaftutvqurvqzfczdryDISCOVERCompaniesPeopleInvestorsFunding RoundsAcquisitionsSchoolsEventsMy SearchesMy ListsFeaturedContributeData SolutionsAboutTermsCareersSitemapEditorial Partners: TechCrunch© 2017 Crunchbase Inc.All rights reserved.Maninder HoraOverviewTimelineContributorsAdd to this ProfileContributeOverviewUpdatePrimary RoleSenior Vice President, Pharmaceutical Development and Manufacturing Operations @ Nektar TherapeuticsGender:MaleLocation:UnknownPerson DetailsUpdateManinder Hora joined Nektar in August 2010 as Senior Vice President, Pharmaceutical Development and Manufacturing Operations to lead management and oversight of Nektar's CMC, bioanalytical and manufacturing operations worldwide. 
Dr. Hora has been in the biopharmaceutical industry for 27 years with demonstrated expertise in process, analytical and pharmaceutical sciences, manufacturing and quality functions for biologics, vaccines, small molecules and drug delivery systems. 
He has led large teams of scientists and engineers to perform early and late stage development as well as lifecycle management CMC activities. He brings to Nektar the experience of registering nine drugs or vaccines products in the United States or Europe. 
Dr. Hora most recently served as Vice President of Product Operations & Quality at Facet Biotech (a spin-off from PDL BioPharma, now a part of Abbott Laboratories). He joined PDL BioPharma in 2006 as Vice President of Process Development and later took charge of Product Operations & Quality. 
From 1986 to 2006, Dr. Hora served in various positions of increasing responsibility at Chiron Corporation (now Novartis) with his last position being Vice President of Process and Product Development during the period 2001 to 2006. Dr. Hora also worked at Smith Kline & French (now Glaxo SmithKline) and Ayerst-Wyeth (now Pfizer) prior to joining Chiron. 
Dr. Hora received his Ph.D. from the Indian Institute of Technology in Bioengineering (Materials) in 1980 and held a Fulbright fellowship at the University of Washington, Seattle. Dr. Hora holds twenty one US Patents and has authored scores of publications and delivered numerous presentations in international forums. He serves as a scientific advisor for Reviva Pharmaceuticals, an emerging research based pharmaceutical company.
Jobs (4)UpdateCurrentSenior Vice President, Pharmaceutical Development and Manufacturing OperationsNektar TherapeuticsAug, 2010 - Current   (almost 7 years)PastStartedEndedTitleCompanyUnknownUnknownVice President of Process and Product DevelopmentChiron CorporationUnknownUnknownVice President of Product Operations & QualityFacet Biotech2006UnknownVice President of Process Development & Product Operations & QualityPDL BiopharmaBoard & Advisor Roles (1)UpdateReviva PharmaceuticalsScientific AdvisorAdd EducationAdd NewsAdd MembershipsAdd ImagesAdd VideosB2CDA-LR37J-YK78Y-A3S53-VWN7U